Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Search
About Us
Sign in
Chemical Industry News, Data & Insights
About Us
Sign in
Home
News
Topics
Sectors
Reports
Events
Clusters
Products
WEEKLY
FOCUS
ALPHA
Products
WEEKLY
FOCUS
ALPHA
Innovation and Product Development news
(page 18)
2 April 2026
Sinopec-led CCUS organization and partners launch Green Design CCUS report and awards
Three international organizations signed an MoU to link green design with CCUS, solicit global innovations, and back an initiative targeting 10 Gt/yr CO2 reduction via large-scale CCUS.
2 April 2026
Chugai: Lilly’s Foundayo (orforglipron) FDA-approved for weight loss
FDA approved an oral GLP-1 for adults with obesity or overweight and weight-related conditions; used with calorie restriction and increased activity to lose and maintain weight
1 April 2026
Halliburton acquires Sekal AS to expand drilling automation services
Acquirer combines automation platforms to expand drilling autonomy with real‑time subsurface, hydraulics and rig controls; deployed in 1,300+ wells and may cut well delivery times up to 25%
1 April 2026
BlueAlp chosen as tech partner for BioBTX circular-aromatics plant
Licensed pyrolysis modules will convert hard-to-recycle plastics into circular BTX aromatics. Plant capacity ~20 kta; modules built now, shipping to site from Dec 2026.
1 April 2026
Celtic Renewables renews circular partnership with Rosebank Distillery
Distillery pot ale will be sent to a nearby biorefinery to make bio‑based chemicals (500 t/yr), extending a 3‑year supply deal; products cut carbon by >60% vs fossil equivalents.
1 April 2026
LKAB: Johan Menckel on presence and responsibility
New CEO pledges presence and clear priorities: modernise mining (automation, electrification, digitalisation), shift to carbon‑free processes, extract critical minerals, and support affected communities.
The right choices in the European chemical industry
Save time with
chemXplore Alpha
Learn more
1 April 2026
Phelan Green selects Honeywell UOP FT Unicracking for Saldanha eSAF
Chosen tech will produce commercial-scale electro‑sustainable aviation fuel in Saldanha Bay; R47bn project to deliver >140,000 t eSAF to EU/UK, construction from Q4 2026, local job creation.
1 April 2026
Reju secures €135m NIKI funding for Chemelot textile regeneration hub
Scale industrial textile-to-textile process converting hard-to-recycle polyester waste into recycled intermediates with ≈50% lower emissions, integrated into efficient, traceable circular supply chains.
1 April 2026
MAIRE/Nextchem awarded early engineering and equipment contract for 60,000 t/y SAF plant in Indonesia
Plant will use palm oil mill effluent and certified used cooking oil, leveraging NX PTU and NX SAF BIO technologies to support the project's FID and Indonesia's domestic SAF development
1 April 2026
Sinopec Begins Construction of Petroleum Engineering Pilot Platform
S1 test well began drilling, starting pilot-platform construction. Platform will validate drilling/completion gear, downhole tools and materials, support full testing and speed tech transfer.
31 March 2026
BASF launches Butyl and 2‑Ethylhexyl Acrylate RE with Avery Dennison
Launches butyl and 2‑ethylhexyl acrylates made using attributed Texas renewable electricity; drop‑in for coatings and adhesives, reducing manufacturing CO2; commercialization supported by partner.
31 March 2026
Symrise launches Cellexora MD: plant‑derived exosomes for skin regeneration
Upcycled Italian apple side-stream extract: 100% natural, stable, water-soluble powder that boosts collagen, soothes skin and reduces wrinkles in 30 days; sustainable and formulation-friendly.
31 March 2026
Kemira completes first US full-scale trial of chlorine-free KemConnect DEX
Trial with Capital Region Water shows a performic-acid, chlorine-free treatment cut bacteria rapidly at low doses, auto-degraded to biodegradable compounds and auto-adjusted dosing.
31 March 2026
LanzaTech Q4 & FY2025 Financial Results
Closed $20M private placement; awarded €40M EU grant; completed LanzaJet share transfers (peak 53%, later ~46% after Series A); revenue $55.8M; net loss $49M; opex -21%
31 March 2026
OMV and XRG form Borouge International
Merger of Borouge, Borealis and NOVA creates global pure‑play polyolefins leader with 13.6 Mtpa capacity, >$500M synergies, advantaged feedstock and investment‑grade ratings
31 March 2026
PPG showcases electrocoat and digital innovations at ECOAT 26
At ECOAT 26, new pretreatment and electrocoat technologies, digital paint‑shop tools and services to cut waste and costs, boost efficiency; exec keynote and interactive demo included.
31 March 2026
Covestro at Techtextil 2026: sustainable, productivity-focused textile solutions
Showcases coatings, adhesive films and TPUs: waterborne/partly bio-based PUs, antimicrobial finishes, high-performance TPU films for electronics/CIPP, recyclable cushioning and SCF-foamable TPUs
31 March 2026
Johnson Matthey DPFi DPF earns Canadian CSA certification
Electrically regenerating diesel particulate filter certified by CSA for Canadian underground mining/tunnelling; also certified by Canmet and VERT and approved by US MSHA.
31 March 2026
BASF launches biomass‑balanced Ultrason® P 3010 BMB PPSU
New Ultrason P 3010 BMB is ISCC‑PLUS certified, 20% biomass‑balanced PPSU (mass‑balance), matches standard grade in properties and certifications, drop‑in replacement made with green electricity.
31 March 2026
Lilly to acquire Centessa Pharmaceuticals for OX2R sleep‑wake portfolio
$38/ADS cash + up to $9 CVR (max $47/sh); upfront equity ~$6.3B (CVR ~$1.5B). Lead OX2R agonist cleminorexton showed positive Phase 2a for narcolepsy and idiopathic hypersomnia. Close expected Q3
31 March 2026
Umicore opens Shanghai innovation center
New 3,600 sqm Shanghai innovation center, first corporate R&D outside Europe; focuses on fuel cells and recycling, expanding to catalysis for renewables, CO2 capture, H2, and local partnerships.
31 March 2026
Messer 2025 results: €4.5bn revenue, €1.4bn EBITDA, €747m investments
Stable 2025: margin held, net debt reduced, staff >12k. Investments in air-separation, on-site/CO2/cylinder plants, helium, decarbonization, R&D/digitalization. 2026 growth expected.
31 March 2026
Topsoe signs FEED deal with Hynfra for Jordan green ammonia
FEED underway for Jordan green ammonia: synthesis tech will convert green H2 to ammonia, avoiding >200,000 t CO2e/yr. FID expected 2027; plant to start 2030; exports planned.
31 March 2026
Sumisho Venture Partners launches ¥10 billion fund
Shifting to a fund structure to enable medium/long‑term, larger lead investments, deepen portfolio engagement and co‑creation, and pursue strategic and financial returns in digital, AI and deep tech
30 March 2026
Dow’s Carbon Footprint Ledger wins 2026 CIO 100 Award
Recognized for enabling verifiable PCF certificates, optimizing low‑GHG production pathways, and integrating supply‑chain, sustainability and finance data to scale trusted low‑carbon product offerings.
30 March 2026
Merck enlicitide decanoate, an oral PCSK9 inhibitor, reduces LDL‑C more than guideline non‑statins at 8 weeks
Phase 3 CORALreef AddOn: enlicitide lowered LDL‑C 64.6% at 8 weeks; 78.2% achieved ≥50% reduction and LDL‑C <55 mg/dL; safety comparable to oral non‑statins; FDA CNPV awarded
30 March 2026
Velocys and SuMo commission Fischer–Tropsch unit at Wednesbury for UK waste-to-SAF
FT unit at Wednesbury is online and stable, validating integration of gasification and FT for waste-to-SAF and supporting ClearSkies demonstration toward modular, scalable SAF production.
30 March 2026
Itabus fleet adopts Enilive HVO
Entire 100-vehicle fleet runs on HVO made from waste, cutting CO2eq by 79.5%. In 2025 it logged 20M km, used over 3M L HVO (53% avg, 75% peak in Dec).
30 March 2026
UBE obtains food-contact approval for UBECycle recycled PE/PA films
Accredited migration testing plus RecyClass‑certified recycling (following Paulowsky acquisition) confirm regulatory compliance and open use of mechanically recycled PE/PA in regulated packaging.
30 March 2026
GSK's bepirovirsen accepted for regulatory review in China for chronic hepatitis B
China NMPA accepted NDA for bepirovirsen after Phase III B-Well trials showed significant functional cure rates in treated CHB patients; granted Breakthrough Therapy; acceptable safety.
← Previous
Next →